Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations
- PMID: 32305586
- PMCID: PMC7162769
- DOI: 10.1016/j.jvsv.2020.04.004
Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations
Comment in
-
Use of low-molecular-weight heparin in COVID-19 patients.J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):900-901. doi: 10.1016/j.jvsv.2020.06.006. Epub 2020 Jun 17. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32561464 Free PMC article. No abstract available.
-
Reply.J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):901. doi: 10.1016/j.jvsv.2020.06.007. Epub 2020 Jul 12. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32663524 Free PMC article. No abstract available.
-
Fish oil and COVID-19 thromboses.J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1120. doi: 10.1016/j.jvsv.2020.07.002. Epub 2020 Jul 15. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32682081 Free PMC article. No abstract available.
References
-
- Bo H., Li Y., Liu G., Ma Y., Li Z., Cao J. Assessing the risk for development of deep vein thrombosis among Chinese patients using the 2010 Caprini risk assessment model: a prospective multicenter study [published online ahead of print December 17, 2019] J Atheroscler Thromb. 2019 doi: 10.5551/jat.51359. - DOI - PMC - PubMed
-
- Cook D.J., Crowther M.A., Meade M.O., Douketis J. VTE in the ICU Workshop Participants. Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care. 2005;20:309–313. - PubMed
-
- Obi A.T., Tignanelli C.J., Jacobs B.N., Arya S., Park P.K., Wakefield T.W. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019;7:317–324. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
